Clinical Trials in the UK / NCT04982393
Active, not recruiting
Observational
BONAPH1DE, A Prospective Observational Study of Patients With Primary Hyperoxaluria Type 1 (PH1)
NCT04982393 · tracked via the Priya Life Science UK tracker
Condition(s) studied
Primary Hyperoxaluria Type 1
Study summary
The purpose of this study is to describe the natural history and progression of patients diagnosed with PH1, and to characterize the long-term real-world safety and effectiveness of lumasiran.
Eligibility
Inclusion Criteria:
* Documented diagnosis of PH1, per physician's determination
Exclusion Criteria:
* Currently enrolled in a clinical trial for any investigational agent
Primary outcome measure(s)
- Incidence of Adverse Events in Lumasiran Treated Patients — Up to 7 years
Trial sites (30)
| Facility | City | Region | Status |
|---|---|---|---|
| Clinical Trial Site | Phoenix | Arizona | |
| Clinical Trial Site | Washington D.C. | District of Columbia | |
| Clinical Trial Site | Boston | Massachusetts | |
| Clinical Trial Site | Rochester | Minnesota | |
| Clinical Trial Site | Cincinnati | Ohio | |
| Clinical Trial Site | Pittsburgh | Pennsylvania | |
| Clinical Trial Site | Dallas | Texas | |
| Clinical Trial Site | Houston | Texas | |
| Clinical Trial Site | Ghent | Belgium | |
| Clinical Trial Site | Liège | Belgium | |
| Clinical Trial Site | Hamilton | Ontario | |
| Clinical Trial Site | Toronto | Ontario | |
| Clinical Trial Site | Laurier | Quebec | |
| Clinical Trial Site | Bordeaux | France | |
| Clinical Trial Site | Lyon | France | |
| Clinical Trial Site | Paris | France | |
| Clinical Trial Site | Berlin | Germany | |
| Clinical Trial Site | Cologne | Germany | |
| Clinical Trial Site | Hamburg | Germany | |
| Clinical Trial Site | Jerusalem | Israel | |
| Clinical Trial Site | Orbassano | Torino | |
| Clinical Trial Site | Milan | Italy | |
| Clinical Trial Site | Verona | Italy | |
| Clinical Trial Site | Amsterdam | Netherlands | |
| Clinical Trial Site | Santa Cruz de Tenerife | Canary Islands | |
| Clinical Trial Site | Barcelona | Spain | |
| Clinical Trial Site | Las Palmas | Spain | |
| Clinical Trial Site | Bern | Switzerland | |
| Clinical Trial Site | London | England | |
| Clinical Trial Site | London | United Kingdom |
More Alnylam Pharmaceuticals trials in the UK
Other trials for the same condition
Official registry record
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT04982393 on ClinicalTrials.gov ↗ ← All trials in the UK